InsidersTradesSigma
XpresSpa Group, Inc. Stock: price and insider trades · United States · SEC (Form 4)
Track the XpresSpa Group, Inc. stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Operating in the Healthcare & Pharma sector, XpresSpa Group, Inc. has logged 37 public disclosures. The latest transaction was filed on 21 June 2022 (Acquisition). Among the most active insiders: Bernstein Bruce. The full history is accessible without an account.
37
Insider Decl.
0
Thresholds
€343,471
8 ops.
Buy Volume
€590,328
11 ops.
Sell Volume
42Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 21 June 2022
Declarations37 total
12,602.394 shares@ US$0.7935100.0% of flowCommon StockSEC:0000950138-22-000172:0
Ideal exit: 14 Mar 2023 (T+270)
5,000 shares@ US$1.10100.0% of flowCommon StockSEC:0000950138-22-000110:0
45,000 shares@ US$1.0622.2% of flowCommon StockSEC:0000950138-22-000108:0
5,000 shares@ US$1.230.9% of flowCommon StockSEC:0000950138-22-000095:0
Ideal exit: 12 Dec 2022 (T+270)
15,000 shares@ US$0.99522.2% of flowCommon StockSEC:0000950138-22-000080:0
31,250 shares0Common StockSEC:0000950138-22-000034:0
62,500 shares0Common StockSEC:0000950138-22-000028:0
31,250 shares0Common StockSEC:0000950138-22-000032:0
31,250 shares0Common StockSEC:0000950138-22-000030:0
62,500 shares0Common StockSEC:0000950138-22-000028
31,250 shares0Common StockSEC:0000950138-22-000034
31,250 shares0Common StockSEC:0000950138-22-000032
31,250 shares0Common StockSEC:0000950138-22-000030
25,000 shares@ US$1.461810.8% of flowCommon StockSEC:0000950138-22-000025
25,000 shares@ US$1.46185.2% of flowCommon StockSEC:0000950138-22-000025:0
2,500 shares@ US$1.6661.2% of flowCommon StockSEC:0000950138-21-000522
Ideal exit: 11 Sept 2022 (T+270)
2,500 shares@ US$1.6660.6% of flowCommon StockSEC:0000950138-21-000522:0
Ideal exit: 11 Sept 2022 (T+270)
63,000 shares@ US$1.431938.9% of flowCommon StockSEC:0000950138-21-000470:0
63,000 shares@ US$1.4319100.0% of flowCommon StockSEC:0000950138-21-000470
20,000 shares@ US$1.3550.0% of flowCommon StockSEC:0000950138-21-000444:0
20,000 shares@ US$1.35100.0% of flowCommon StockSEC:0000950138-21-000444
107,500 shares@ US$1.425321.3% of flowCommon StockSEC:0000950138-21-000423:0
Ideal exit: 16 May 2022 (T+270)
107,500 shares@ US$1.425344.0% of flowCommon StockSEC:0000950138-21-000423
Ideal exit: 16 May 2022 (T+270)
24,602 shares@ US$1.39100.0% of flowCommon StockSEC:0000950138-21-000421
Ideal exit: 17 May 2022 (T+270)
24,602 shares@ US$1.3950.0% of flowCommon StockSEC:0000950138-21-000421:0
Ideal exit: 17 May 2022 (T+270)
25 of 37 declarations
About XpresSpa Group, Inc.
XpresSpa Group, Inc. is a U.S.-listed company that has traded on NASDAQ under the ticker XSPA. Originally known as FORM Holdings, it was renamed XpresSpa Group in 2018 and later rebranded again as XWELL in 2022 to reflect a broader strategic shift toward wellness and health-oriented services. The company is headquartered in New York, United States, which fits its long-standing focus on airport-based consumer services and travel-related health offerings. The company’s core business has historically been airport spa services under the XpresSpa brand. That concept centers on fast, premium wellness treatments for travelers, including massage, nail care, skin care, and related travel/wellness products. XpresSpa has built its identity around a highly specific niche: high-traffic airport locations where customers are time-constrained but willing to pay for convenience, relaxation, and personal care. This airport-only focus has long differentiated the company from broader salon, spa, or retail chains. Over time, the group expanded beyond classic spa services into travel health and screening-related offerings. During the COVID-19 period, XpresCheck became a visible part of its portfolio, supporting airport testing and, later, broader biosurveillance and public-health initiatives at select major airports. More recently, company disclosures indicate a continued emphasis on wellness as a wider category, with the XpresSpa brand remaining the flagship business while other initiatives such as Treat, XpresTest, and Naples Wax Center have featured in the corporate structure. The exact mix of these businesses can change as management refines the portfolio. From a competitive standpoint, XpresSpa is best viewed as a specialized niche operator rather than a large-scale wellness chain. Its competitive advantage comes from airport real estate access, brand recognition among frequent travelers, and a service model tailored to short dwell times. At the same time, the business is exposed to the cyclicality of air travel, airport lease economics, and the operational complexity of running consumer services inside regulated transportation hubs. For investors, that means XSPA is a small-cap U.S. travel-wellness story with meaningful execution risk and a strong dependence on passenger traffic trends. Recent milestones have centered on strategic repositioning, continued airport wellness operations, and the extension of health-related programs in major hubs. The company has also highlighted its role in wellness innovation at airports, blending retail, services, and health-oriented offerings. Overall, XpresSpa Group remains an unusual hybrid between travel retail, wellness services, and airport health solutions, listed on NASDAQ in the United States.
